Pneumococcus is the most severe cause of bacterial meningitis resulting in a 20-30% of hospital mortality an up to a 40% rate of intracranial complications such as brain edema, hydrocephalus and intracranial hemorrhage 1, 5 . Even patients with good apparent recovery may present sequelae; moreover, around one-third of the patients have cognitive impairments 5 . These impairments consist mainly of cognitive slowness, learning impairment, deafness, blindness, neuropsychiatric impairments, cerebral palsy, seizure disorders and mental retardation 6 . The objective of this paper was to review some aspects of the meningitis pathophysiology caused by S. pneumoniae and discuss some possible therapeutic adjunctive approaches.
MECHANISMS OF BACTERIAL COLONIZATION
The pneumococcus habitat is the human nasopharynx mucosa with a prevalence of about 40% in infants and 15% in adults 7 . The bacterium is transferred among people by coughing and sneezing. It has to face the natural barrier, the host' s immune system and up to 700 different microbial species that can colonize the same niche 8, 9 . S. pneumoniae colonizes the nasopharynx by degradation of the mucus by exoglycosidases such as neuraminidase A, β-galactosidase, β-N-acetylglucosaminidase, and neuraminidase B decreasing mucus viscosity 10 . S. pneumoniae produces the pneumolysin that is a major exotoxin. It decreases epithelial cell ciliary' s beating and enhances bacterial adherence 11 . Pneumococcus also expresses the enzymes peptidoglycan, N-acetylglucosaminedeacetylase A, and O-acetyltransferase that provides resistance to lysozyme 12 and it also produces IgA1 protease, which cleaves IgA, the major class of Ig in secretions, promoting binding to the respiratory mucosa 13 . S. pneumoniae may transmigrate through the epithelial cells by binding the phosphorylcholine with the receptor of the platelet-activating factor (PAF) or by connecting the pneumococcal choline-binding protein with the epithelial polymeric immunoglobulin receptor, which transports the bacterium to the basal membrane of the host' s epithelial cell and may lead to invasive illness 8, 14 .
CENTRAL NERVOUS SYSTEM BACTERIAL INVASION
The CNS protection is formed by bony skull, the leptomeninges, the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier 15 . The BBB is constituted of brain microvascular endothelial cells, astrocytes, and pericytes. It maintains the neural microenvironment by regulating the passage of molecules into and out of the brain, and preserves the brain from whatever microorganisms and toxins that comes from the blood 16 . The S. pneumoniae crosses the BBB and interacts with cell-wall phosphorylcholine, the platelet-activating-factor receptor and cross the BBB without any evidence of intercellular tight-junction disruption or detection of microorganism between cells through transcellular traversal mechanism 16 . It can also crosses intercellularly by disruption of the interepithelial tight junctions 8 . The pneumococcus replication within the subarachnoid space occur concurrently with the release of the bacterial products such as peptidoglycan, cell wall fragments that are highly immunogenic and may lead to an increased inflammatory response in the host 15 . S. pneumoniae is recognized by antigen-presenting cells binding to a pattern recognition receptors. The main pattern recognition receptors involved in initial pneumococcus sensing in the CNS are Tolllike 2 receptors (TRL-2 or CD282) that is recognized by peptidoglycans and lipoteichoic acids 17 , Toll-like 4 receptors (TRL-4 or CD284) that are recognized by exotoxin pneumolysin 18 and the Toll-Like 9 receptors (TRL-9 or CD289), an intracellular pattern recognition receptor that is activated by CpG in bacterial DNA 19 . Family members of the NOD-like receptors (NLRs), which are intracellular, play essential roles on innate immunity by detecting intracellular pathogen-associated molecular patterns 20 . When they are activated, they induce the activation of nuclear factor kappa B (NF-κB) or mitogen-activated protein kinase (MAPK) pathways and inflammatory caspases 21 . TRL-2 and TRL-4 use a common intracellular adapter protein known as myeloid differentiation factor 88 (MyD88) 8 . MyD88 signals for NF-κB activation and subsequent up-regulation of pro-inflammatory mediators. MyD88-deficient mice displayed a markedly diminished inflammatory host response in the CNS, as an evidenced of the reduced CSF pleocytosis and expression of cytokines, chemokines and complement factors 22 . Furthermore, MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis; it is required for mounting a robust host immune response to S. pneumoniae in the CNS 23 . NF-κB comprises a closely related family to transcription factors, which play a key role on the expression of genes involved in the development of accessory cell and lymphocyte populations, expressing numerous proteins involved in inflammation and immune response 24 . It is also a transcriptional activator of many genes involved in the pathogenesis of pneumococcal meningitis, such as, TNF-α, IL-1β, inducible nitric oxide synthase and intercellular adhesion molecules 25, 26 ( Figure) .
INFLAMMATION Cytokines
Many brain cells such as astrocytes, glial cells, endothelial cells, ependymal cells, and resident macrophages can produce cytokines and pro-inflammatory molecules in response to bacterial replication and its components 27 . TNF-α is a 158 amino acid cytokine considered a pro-inflammatory molecule, enhancing the immune response to help speed-up the pathogens elimination and the resolution of the inflammatory challenge 28 . TNF-α leads to NF-κB activation in the CSF and brain resident cells, which regulates the expression of many pro-inflammatory mediators 29 . In animal models for pneumococcal meningitis, TNF-α was produced in the first 6 h of the immune response 30 . Intrathecal administration of TNF-α results in a similar pathophysiological characteristic of bacterial meningitis such as BBB disruption, facilitating bacterial traversal into the CSF 31 , on the other hand, TNF-α deficient mice increased mortality and spatial memory deficits 32 . TNF-α is a marker of the acute inflammatory response, however, it' s also essential for an adequate host immune response 8 . IL-1β is a pro-inflammatory cytokine, produced by perivascular, mononuclear phagocytes, glial cells, and meningeal macrophages that increase the expression of nearly all other cytokines such as TNF-α, IL-6, IFN-γ, and chemokines. IL-1β has potent stimulatory effects on granulocytes white cells; it promotes the adhesion of neutrophils and monocytes in endothelial cells 33 . IL-1β is found in the CSF of patients with bacterial meningitis 34 , furthermore, in animal models it was produced in the first 24 h after pneumococcal meningitis induction 30 , although intrathecal administration of IL-1β did not lead to CSF pleocytosis or brain edema 35 . However, the mortality was significantly higher and earlier in the course of the disease among IL-1 receptor (IL-1R) gene-deficient mice, demonstrating that endogenous IL-1β is required for an adequate host defense in pneumococcal meningitis 36 . IL-6 is produced by monocytes, endothelial cells, and astrocytes primarily in response to IL-1β 37 . It has predominantly pro-inflammatory effects such as potent inducer of acutephase proteins, fever and leukocytes 38 but it also acts as an anti-inflammatory cytokine, indeed, the lack of IL-6 enhances inflammatory response but decreases vascular permeability in bacterial meningitis 39 . IL-6 gene-deficient mice showed impaired defense against pneumococcal pneumonia 40 . IL-10 is a potent immunosuppressive cytokine, produced by monocytes, macrophages, B and T lymphocytes, brain cells such as neurons and microglia 41 . Elevated levels have been found in the CSF in patients with bacterial meningitis 42 , it leads to macrophage and monocyte deactivation and inhibits the cytokines production such as TNF-α and IL-6 and the release of reactive oxygen species 43 . IL-10 gene-deficient mice were associated with higher levels of TNF-α and IL-6 in animal model of pneumococcal meningitis 36 . TGF-β is an anti-inflammatory cytokine that is expressed in neurons and glial cells, maintains T cell tolerance to self or innocuous environmental antigens via its direct effects on the differentiation, homeostasis and regulatory T cells 44 .
It suppresses the production of IL-1β, IL-6 and TNF-α from microglia in vitro 45 , moreover, endogenous TGF-β suppresses the host defense in the CSF of mice with S. pneumoniae meningitis 3 . The collective activity of TGF-β and IL-10 ensures a controlled inflammatory response specifically targeting pathogens without evoking excessive immunopathology to the self-tissues 44 . Chemokines are chemoattractant cytokines, which play key roles on the accumulation of inflammatory cells in the inflammation site. Increased chemokines levels have been reported in the CSF of patients with bacterial meningitis. IL-8 is produced by wide variety cell types such as monocytes, macrophages through stimuli of the live bacteria, TNF-α, and IL-β. It is important to regulate the acute inflammatory response and it' s rapidly synthesized in the inflammation sites with the function to recruit acute inflammatory cells 46 . In pneumococcal meningitis treatment with a monoclonal antibody to IL-8 given intravenously attenuated the pleocytosis in rabbits. IL-8 plays an important role on the recruitment of neutrophils during experimental pneumococcal meningitis 47 .
Matrix metalloproteinases Matrix metalloproteinases (MMPs) is a family Zn
2+ and Ca 2+ dependent endopeptidases, which is secreted by all cell types in the CNS and serve as effectors of cell migration, tissue remodeling, degrade constituents of the BBB Figure. Summary of the development of host pattern recognition receptors involved in sensing S. pneumoniae. Tolllike 2 is activated by pneumococcal cell wall peptidoglycan, lipoteichoic acids and Toll-like-4 is activated by pneumolysin, both use a common intracellular adapter protein MyD88 to activated NF-κB. NOD-2 is activated by peptidoglycan and also activated NF-κB, inducing transcription of several proinflammatory mediators.
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Pro-inflammatory cytokines/chemokines and interacts with the cytokines 48 . Gelatinases (MMP-2 and MMP-9) have shown to induce BBB breakdown and facilitate leukocyte extravasation in experimental bacterial meningitis 49 , furthermore, patients with bacterial meningitis present high concentrations of MMP-939 and MMP-8 in the CSF, indeed, high concentrations of MMP-9 were correlated with risk factor for the development of postmeningitis neurological sequelae 48 . In a rat model, adjuvant treatment with dexamethasone resulted in a lower MMP-9 mRNA 50 , in addition, combining the MMP and TNF-α inhibitors led to a decrease incidence of the seizures and mortality, furthermore, neuronal necrosis in the cortex and apoptosis in the hippocampus were attenuated in rats submitted by pneumococcal meningitis 51 .
Oxidative stress Bacterial components are recognized by Toll-like receptors or other pathogen recognition receptors that lead to the activation of NF-κB 21 . It triggers the expression of pro-inflammatory cytokines, as consequence, polymorphonuclear are attracted, activated and released in large amounts superoxide anion (O 2 -) and nitric oxide (NO), leading to the peroxynitrite formation (ONOO -) 52 . The release of large amounts of reactive nitrogen species (RNS) and reactive oxygen species (ROS) had been documented in patient's populations, likewise, in animal model by pneumococcal meningitis and might contribute to the development of neuronal damage 52 . Treatment with superoxide dismutase mimetics and catalase (hydrogen peroxide scavenger) inhibited brain edema formation 53, 54 ; antibiotic therapy prevented, in part, the oxidative stress in experimental pneumococcal meningitis 55 . Brain resident cells produce O 2 -, H 2 O 2 as part of the host immune response to invasive bacterial infection, in addition, S. pneumoniae itself is also an important source of H 2 O 2 , which is not only able to cause direct cytotoxic damage but also reacts with the host's NO to form the highly reactive species ONOO 56 . Peroxynitrite can crosses membranes, activate the MMPs, leads to DNA damage, protein carbonylation and cause lipid peroxidation 52 , leading to a membrane integrity loss, energy depletion, contributing to cell injury during pneumococcal meningitis 57 .
NEURONAL DAMAGE AND TARGETS FOR ADJUNCTIVE THERAPY
Pneumococcal meningitis causes sequelae including sensory-motor deficits, hearing loss, deafness and neuro intellectual impairment, including deficits in learning and memory. These neurofunctional consequences occur in up to 30% of survivors patients 5 . The neuronal damage is caused by the strong inflammatory reaction and direct effects of the microorganism 32 . Significant injury during bacterial meningitis arises from mechanisms of neuronal apoptosis, particularly in the hippocampus; in autopsies cases of bacterial meningitis were found apoptosis of neurons in the dentate gyrus 58 . Apoptosis can involve both the caspasedependent and the caspase-independent pathway 59 . The caspase-independent pathway is triggered by the pneumolysin and H 2 O 2 that are produced by S. pneumoniae. The actions of these toxins result in an increase in ROS and calcium, resulting in mitochondrial dysfunction that leads to the release of apoptosis-inducing factor into the cytosol 56, 59 . However, the caspase-dependent pathway occurs later, and pneumococcal cell-wall components trigger the required host inflammatory response from the leukocytes. p53 tumor suppressor protein and ATM protein kinase (ATM) as upstream mediators that converge on the mitochondria to initiate the release of cytochrome c, which is necessary to form the apoptosome forming apoptotic protease activating factor-1 (Apaf-1) and active caspase-9 that results in the activation of caspase-359.
In the pre-antibiotic era when acute bacterial meningitis was described the mortality rate was from 90 to 100%. Although, nowadays, with the development of highly effective antibiotics, more precocity in diagnosis with precise diagnostic methods as immunological and molecular biology methods, supportive care in intensive care units the mortality doesn't decrease. The mortality of S. pneumoniae is (16-37%), N. meningitidis (5%), Haemophilus influenzae (3%). This maintenance of mortality is explained by inflammation in the subarachnoid space caused by the generation of bacterial cell wall components in CSF during treatment of meningitis with antibiotics 2, 60, 61 . Bacterial cell wall components stimulate the release of inflammatory cytokines in the CNS such as TNF-α, IL-1β, and prostaglandins.
Possible therapeutic approaches to decrease the harmful effects of TNF and/or IL-1-β are investigated in vitro and animal model and might include: a) Drugs or procedures to decrease their production, block their biologic activity or enhance removal from the circulation; b) Passive immunization with antibodies against TNF and IL-1, limitation is the BBB even during inflammation; c). Drugs that interfere with IL-1 induced arachidonic acid metabolites.
Corticosteroids are largely used as adjunctive therapy for acute bacterial meningitis since the 90 decade.
In addition to corticosteroids, several other adjunctive approaches may be useful (Table) [60] [61] [62] [63] [64] [65] [66] [67] ; although there is no proved clinical evidence for use of these therapies and some are only experimental. The use of bactericidal but nonbacteriolitic antibiotics to reduce endotoxin and other injurious substance release into CSF as rifampicin and daptomycin have been investigated in animal models of pneumococcal meningitis 63 . Thalidomide acts by blocking TNF release from microglia 65 . An enhanced lifespan of activated neutrophils in the CSF contributes to massive leukocyte accumulation and host-driven cytotoxicity. Roscovitine, a purine derivative References that induces apoptosis in neutrophils, is studied in mouse models. TNF-α inhibitor decrease TNF-α levels and pleocytosis in CSF 68 , blocking IL-6 intravenously in a rat model of pneumococcal meningitis reduced also pleocytosis 69 and TGF-β2 administrated intraperitoneally reduced the subarachnoid inflammation in rats with pneumococcal meningitis 54 . Intracisternal administration of the caspase-3 inhibitor reduced apoptosis in the dentate gyrus hippocampal 70 and blocking of caspase-1 demonstrated lower levels of IL-1β 71 .
Corticosteroids are highly effective in reducing IL-1β production in vitro and in vivo. A meta-analysis that included all double-blinded, randomized, placebo-controlled trials since 2001 that evaluated dexamethasone in bacterial meningitis concluded that adjunctive dexamethasone in bacterial meningitis may reduce mortality and hearing loss for patients in developing countries. There may be no benefit for individuals in developing nations with a high prevalence of HIV infection 66 . The intravenous dose of dexamethasone proposed is 2 x 0.4 mg/kg/24h or 4 x 8-12mg/24h, during 48 to 96 hours. The first dose was delivered prior or concomitantly with the first dose of parenteral antibiotic 67 . In previous studies we verified dexamethasone treatment reverses cognitive impairment but increases brain oxidative stress in rats submitted to pneumococcal meningitis 72 . Adjunctive dexamethasone in bacterial meningitis reduces mortality and hearing loss for patients but still needs more evaluation. 
FINAL REMARKS
Despite the significant advances in treatment, pneumococcal meningitis remains one of the most important infectious diseases of the CNS with high mortality and morbidity. Experimental animal model with its limitations continues to provide the understanding of this complex pathophysiology disease and propose new therapies adjunctive.
